Cerebral Palsy Foundation is ranked #24 of 39 medical research organizations in New York, NY, with an America's Best Score of 68 out of 100, based on its 2025 Form 990.
Cerebral Palsy Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H23Z). Contributions are tax-deductible.
3 Columbus Circle 15Th Floor, New York, NY 10019-8720
Among the 61 scored medical research organizations in New York, Cerebral Palsy Foundation holds 3.9 months of operating reserves (peer median 13.5 months), runs a typical yearly surplus of 0.9% (peers: surplus of 3.4%), and has grown spending 36.2% a year (peers: grown spending 7.0% a year).
In fiscal year 2025 it reported $4,490,185 in revenue and $5,347,918 in expenses, with contributions making up 90.1% of revenue.
The foundation develops and spearheads initiatives designed to change lives today for people with cerebral palsy through research, innovation, and collaboration.
Main program · fiscal year 2025
The foundation provides financial support to rigorously reviewed, scientifically important research relevant to cerebral palsy and other developmental disabilities. The foundation also provides medical expertise, as requested by other organizations, and serves as a resource for the international public, clinicians, and policy-makers about best health care practices, prevention, and curative strate… Read more
The foundation provides financial support to rigorously reviewed, scientifically important research relevant to cerebral palsy and other developmental disabilities. The foundation also provides medical expertise, as requested by other organizations, and serves as a resource for the international public, clinicians, and policy-makers about best health care practices, prevention, and curative strategies for cerebral palsy. The foundation is also focusing its attention on research directed at issues of early diagnosis, mechanisms of nervous system injury and repair, regenerative treatments, neurological rehabilitation, orthopedic rehabilitation and engineering solutions, as well as research to prevent the secondary neuromuscular, musculoskeletal, and cardiovascular complications seen in adults with cerebral palsy. There are approximately 1 million children and adults in the USA with cerebral palsy and related developmental disabilities, more clinical and basic biomedical research is urgently needed for improving neurological functions, preventing medical complications, and optimizing quality of life in these individuals from infancy through adulthood.
$5,121,556 spent
Where each dollar went · fiscal year 2025
Of every dollar it spent, 96¢ went to programs, 3¢ to management and 1¢ to fundraising.
Programs $5,121,556
Management $168,903
Fundraising $57,459
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
96%
Meets
Compared with New York peers
Measure
This organization
Peer median
Operating reserves
3.9 mo
13.5 mo
Typical margin
+0.9%
+3.4%
Spending growth
+36.2% / yr
+7.0% / yr
Debt load
17.1%
13.5%
Peers: the 61 New York medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$4,490,185Fiscal year 2025
Expenses$5,347,918Fiscal year 2025
Total assets$2,066,811Fiscal year 2025
Total liabilities$352,718Fiscal year 2025
Fiscal year ending September2025
Revenue$4,490,185
Expenses$5,347,918
Net income−$857,733
Net assets$1,714,093
Notable sources of revenue
Percent of total revenue
Contributions
$4,046,099
90.1%
Program services
$444,538
9.9%
Investment income
$69,732
1.6%
Other (net)
−$70,184
−1.6%
Assets / debt
Total assets
$2,066,811
Total liabilities
$352,718
Net assets
$1,714,093
Compensation
Not in our extract for this year.
Fiscal year ending September2024
Revenue$4,686,145
Expenses$4,684,411
Net income$1,734
Net assets$2,534,208
Notable sources of revenue
Percent of total revenue
Contributions
$4,191,716
89.4%
Program services
$489,336
10.4%
Investment income
$66,921
1.4%
Other (net)
−$61,828
−1.3%
Assets / debt
Total assets
$2,792,533
Total liabilities
$258,325
Net assets
$2,534,208
Compensation
Not in our extract for this year.
Fiscal year ending September2023
Revenue$4,021,273
Expenses$3,899,013
Net income$122,260
Net assets$2,432,389
Notable sources of revenue
Percent of total revenue
Contributions
$3,811,008
94.8%
Program services
$208,807
5.2%
Investment income
$57,617
1.4%
Other (net)
−$56,159
−1.4%
Assets / debt
Total assets
$2,675,260
Total liabilities
$242,871
Net assets
$2,432,389
Compensation
Not in our extract for this year.
Fiscal year ending September2022
Revenue$2,151,754
Expenses$2,116,457
Net income$35,297
Net assets$2,268,643
Notable sources of revenue
Percent of total revenue
Contributions
$1,916,963
89.1%
Program services
$230,538
10.7%
Investment income
$5,085
0.2%
Other (net)
−$832
−0.0%
Assets / debt
Total assets
$2,336,868
Total liabilities
$68,225
Net assets
$2,268,643
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?